Medicare Part D coverage · delgocitinib · RxCUI 2721172
delgocitinib 20 MG/ML Topical Cream [Anzupgo]
Per the CMS 2026 Part D formulary file, delgocitinib 20 MG/ML Topical Cream [Anzupgo] is covered by 193 Medicare Part D plans (3.8% of enrollable products), averaging Tier 4.1, with prior authorization required on 85.7% of covering formularies.
- 3.8%
- Plan coverage
- 193
- Plans covering
- T4.1
- Avg tier
- 85.7%
- Prior auth required
What the CMS Formulary Data Shows for delgocitinib 20 MG/ML Topical Cream [Anzupgo]
Per the CMS 2026 Part D formulary file, delgocitinib 20 MG/ML Topical Cream [Anzupgo] (RxNorm concept RXCUI 2721172, generic name delgocitinib) appears on 14 distinct formulary files spanning 193 Medicare Part D plan offerings - 3.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.1.
Real-world access to delgocitinib 20 MG/ML Topical Cream [Anzupgo] depends on utilization management as much as tier placement: 85.7% of covering formularies require prior authorization. 0% require step therapy. 85.7% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry delgocitinib 20 MG/ML Topical Cream [Anzupgo] today.
Coverage Details
- Formularies covering
- 14
- Plans covering
- 193
- Coverage rate
- 3.8%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 85.7% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 85.7% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering delgocitinib 20 MG/ML Topical Cream [Anzupgo]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | Yes | $0 | MA |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Community Blue Medicare HMO Signature (HMO) | Highmark Western and Northeastern New York Inc. | T5 | Yes | $0 | NY |
| Community Blue Medicare HMO Merit (HMO) | Highmark Western and Northeastern New York Inc. | T5 | Yes | $0 | NY |
| Community Blue Medicare PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Community Blue Medicare Plus PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Merit (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Distinct (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Community Blue Medicare Plus PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue Plus PPO Merit (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Community Blue Medicare PPO Signature (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Complete Blue PPO Merit (PPO) | Highmark Senior Health Company | T5 | Yes | $0 | PA |
| Community Blue Medicare HMO Signature (HMO) | Highmark Choice Company | T5 | Yes | $0 | PA |
| Security Blue HMO-POS ValueRx (HMO-POS) | Highmark Choice Company | T5 | Yes | $0 | PA |
| Community Blue Medicare HMO Signature (HMO) | Highmark Choice Company | T5 | Yes | $0 | PA |
| Together Blue Medicare HMO Signature (HMO) | Highmark Choice Company | T5 | Yes | $0 | PA |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is delgocitinib 20 MG/ML Topical Cream [Anzupgo] covered by Medicare Part D?
Yes, delgocitinib 20 MG/ML Topical Cream [Anzupgo] is covered by 193 Medicare Part D plans (3.8% of all Part D formularies).
What tier is delgocitinib 20 MG/ML Topical Cream [Anzupgo] on Medicare Part D plans?
delgocitinib 20 MG/ML Topical Cream [Anzupgo] averages Tier 4.1 across Part D plans, ranging from Tier 1 to Tier 5.
Does delgocitinib 20 MG/ML Topical Cream [Anzupgo] require prior authorization?
85.7% of Part D formularies require prior authorization for delgocitinib 20 MG/ML Topical Cream [Anzupgo]. Step therapy: 0%. Quantity limits: 85.7%.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- brivaracetam 10 MG Oral Tablet [Briviact] T4.1
- rifaximin 550 MG Oral Tablet [XIFAXAN] T4.1
- tenofovir disoproxil fumarate 200 MG Oral Tablet [Viread] T4.1
- pomalidomide 1 MG Oral Capsule T4.1
- 1 ML benralizumab 30 MG/ML Prefilled Syringe [Fasenra] T4.1
- deferasirox 250 MG Tablet for Oral Suspension T4.1
Similar prior-authorization rate
- 0.5 ML filgrastim-ayow 0.6 MG/ML Prefilled Syringe [Releuko] 85.7% PA
- 0.8 ML filgrastim-ayow 0.6 MG/ML Prefilled Syringe [Releuko] 85.7% PA
- pitolisant 4.45 MG Oral Tablet [Wakix] 85.7% PA
- crinecerfont 25 MG Oral Capsule [Crenessity] 85.7% PA
- abiraterone acetate 250 MG Oral Tablet 85.5% PA
- 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution 86% PA